Somatic Mosaicism in Twins Discordant for Childhood Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorChildren's Oncology Group

About this trial

Somatic mosaicism in cancer associated genes is one potential explanation for discordance in childhood cancer that has not been fully explored to date. This pilot study will focus on twins with central nervous system (CNS) tumors who are identified through the Children's Oncology Group's Project: EveryChild (PEC) registry or volunteer.

Eligibility criteria

Qualifiers

Newly diagnosed patient with CNS tumor or have recurrent disease and enrolled on APEC14B1.

Patient must have same sex twin. Note: (history of) treatment on a COG therapeutic trial is not required.

Patients must be diagnosed at < 19 years of age at the time of diagnosis.

A family is eligible to participate if the twin with the CNS tumor is deceased but has a blood sample banked through APEC14B1.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Biospecimen collection
  • Questionnaire Administration

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators

Children's Oncology Group

Lead sponsor

National Cancer Institute (NCI)

Collaborator